SAN MATEO, Calif., June 3, 2008 (PRIME NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq:PTIE) today announced that management is scheduled to present at the following investor conferences:
* Goldman Sachs Global Healthcare Conference in Laguna Niguel,
California
Tuesday, June 10th at 3:20 p.m. Pacific Time
* Needham & Company Biotechnology and Medical Technology Conference
in New York
Thursday, June 12th at 9:00 a.m. Eastern Time
To access a webcast of the live events please visit Pain Therapeutics' web site, www.paintrials.com. A replay will also be available through July 12, 2008.
About Pain Therapeutics, Inc.
Pain Therapeutics, Inc. is a biopharmaceutical company that develops novel drugs. In December 2007, we announced that Remoxy(tm), an abuse-resistant, long-acting version of oxycodone, met the primary endpoint (p less than 0.01) of a pivotal Phase III study in over 400 patients with osteoarthritis; as a result, we plan to file an NDA for Remoxy in Q2 2008. We also have other drug candidates in clinical programs, including a novel radio-labeled monoclonal antibody to treat metastatic melanoma, as well as PTI-202 and Oxytrex(tm). In addition, we are working on a new treatment for patients with hemophilia. The FDA has not yet evaluated the merits, safety or efficacy of our drug candidates.